Share ownership InnoCan Pharma Corporation

INNO

CA45783P1027

Pharmaceuticals

Market Closed - Canadian Securities Exchange Other stock markets 12:28:59 2025-01-24 pm EST			5-day change	1st Jan Change
0.1700 ^CAD	-8.11%		-5.56%	-19.05%

Dec. 31	Innocan Pharma Closes Private Placement for $635,444	MT
Dec. 30	InnoCan Pharma Corporation announced that it has received CAD 0.635445 million in funding	CI

Share class: InnoCan Pharma Corporation

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	286,938,271	222,340,565 ( 77.49 %)	0	77.49 %

Major shareholders: InnoCan Pharma Corporation

Name	Equities	%	Valuation
Solsken Ltd. 17.33 %	49,726,309	17.33 %	7 M $
Ron Abraham Mayron 2.474 %	7,098,885	2.474 %	972 547 $
Iris Bincovich 2.031 %	5,828,010	2.031 %	798 437 $
Eyal Flom 0.8898 %	2,553,055	0.8898 %	349 769 $
PP-Asset Management GmbH 0.1840 %	528,000	0.1840 %	72 336 $
Roni Kamhi 0.1549 %	444,444	0.1549 %	60 889 $
Ralph Bossino 0.1092 %	313,333	0.1092 %	42 927 $
Nelson Halpern 0.1058 %	303,666	0.1058 %	41 602 $
Joshua Lintern 0.0710 %	203,666	0.0710 %	27 902 $
Peter Bloch 0.000000 %	0	0.000000 %	- $

Breakdown by shareholder type

Other	17.33%
Individuals	5.84%
Institutional	0.18%
Unknown	76.65%

Based on 1000 largest holdings

Geographical origin of shareholders

Canada	17.33%
Individuals	5.84%
Germany	0.18%

Based on 1000 largest holdings

Innocan Pharma Corporation is an Israel-based company active in the pharmaceuticals and wellness sectors. In the pharmaceuticals sector, the Company aims to provide a safe, non-opioid chronic pain management solutions for both animals and humans. To achieve this aim, the Company developed a CBD-loaded liposome drug delivery platform with exact dosing, prolonged and controlled release of synthetic CBD for non-opioid pain management. In the wellness sector, the Company develops and markets a wide portfolio of high-performance self-care and beauty products to promote a healthier lifestyle. Under this segment Innocan established a Joint Venture (BI Sky Global Ltd.) that focused on advanced, targeted online sales.

Employees

Sector

Pharmaceuticals

Calendar

2025-03-26 - Q4 2024 Earnings Release (Projected)

More about the company